MA37532B1 - Composition pharmacologique de palmarosa (huile essentielle) à effet antibactérien sur d’aaggregatibacter actinomycetemcomitans - Google Patents

Composition pharmacologique de palmarosa (huile essentielle) à effet antibactérien sur d’aaggregatibacter actinomycetemcomitans

Info

Publication number
MA37532B1
MA37532B1 MA37532A MA37532A MA37532B1 MA 37532 B1 MA37532 B1 MA 37532B1 MA 37532 A MA37532 A MA 37532A MA 37532 A MA37532 A MA 37532A MA 37532 B1 MA37532 B1 MA 37532B1
Authority
MA
Morocco
Prior art keywords
palmarosa
essential oil
antibacterial effect
actinomycetemcomitans
aaggregatibacter
Prior art date
Application number
MA37532A
Other languages
English (en)
Other versions
MA37532A1 (fr
Inventor
Leila Lakhdar
Abdellah Farah
Oumkeltoum Ennibi
Original Assignee
Université Mohammed V De Rabat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Université Mohammed V De Rabat filed Critical Université Mohammed V De Rabat
Priority to MA37532A priority Critical patent/MA37532B1/fr
Priority to PCT/MA2014/000057 priority patent/WO2016076688A1/fr
Publication of MA37532A1 publication Critical patent/MA37532A1/fr
Publication of MA37532B1 publication Critical patent/MA37532B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/121—Ketones acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

L’application de l’effet antibactérien de l’huile essentielle de palmarosa (cymbopogon martinii) d’origine marocaine sur une souche bactérienne orale virulente; aggregatibacter actinomycetemcomitans clone jp2. Cette souche originelle n’a jamais fait l’objet de tests antimicrobiens à base d'huiles essentielles. Cette nouvelle application englobe aussi bien la méthodologie que les résultats obtenus. La technique utilisée est une méthode simple, claire, basée sur la preuve et offrant une meilleure précision et une meilleure reproductibilité des résultats.
MA37532A 2014-11-13 2014-11-13 Composition pharmacologique de palmarosa (huile essentielle) à effet antibactérien sur d’aaggregatibacter actinomycetemcomitans MA37532B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MA37532A MA37532B1 (fr) 2014-11-13 2014-11-13 Composition pharmacologique de palmarosa (huile essentielle) à effet antibactérien sur d’aaggregatibacter actinomycetemcomitans
PCT/MA2014/000057 WO2016076688A1 (fr) 2014-11-13 2014-12-31 Composition pharmacologique de palmarosa (huile essentielle) à effet antibactérien sur aggregatibacter actinomycetemcomitans clone jp2

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MA37532A MA37532B1 (fr) 2014-11-13 2014-11-13 Composition pharmacologique de palmarosa (huile essentielle) à effet antibactérien sur d’aaggregatibacter actinomycetemcomitans

Publications (2)

Publication Number Publication Date
MA37532A1 MA37532A1 (fr) 2016-06-30
MA37532B1 true MA37532B1 (fr) 2017-01-31

Family

ID=52684612

Family Applications (1)

Application Number Title Priority Date Filing Date
MA37532A MA37532B1 (fr) 2014-11-13 2014-11-13 Composition pharmacologique de palmarosa (huile essentielle) à effet antibactérien sur d’aaggregatibacter actinomycetemcomitans

Country Status (2)

Country Link
MA (1) MA37532B1 (fr)
WO (1) WO2016076688A1 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007210922A (ja) * 2006-02-08 2007-08-23 Kitasato Gakuen 口腔用組成物

Also Published As

Publication number Publication date
MA37532A1 (fr) 2016-06-30
WO2016076688A1 (fr) 2016-05-19

Similar Documents

Publication Publication Date Title
CL2020001048A1 (es) Anticuerpos monoclonales contra bcma. (divisional solicitud 201800281)
CL2021000343A1 (es) Inhibidores peptídicos del receptor de interleucina 23 (divisional de la solicitud n° 201800128)
CY1122306T1 (el) Συνθεσεις που περιλαμβανουν bakthpiaka στελεχη
MA49903A (fr) Sulfonylureés et sulfonylthioureés en tant qu'inhibiteurs de nlrp3
AR106768A1 (es) Composiciones que comprenden cepas bacterianas
NZ725569A (en) Lubricant formulations
MA46109A (fr) Formulations d'anticorps inhibiteurs de masp-2 hautement concentrées à faible viscosité, kits et méthodes
MA48797A (fr) Variants de l'endonucléase cblb , compositions et procédés d'utilisation
BR112017005762A2 (pt) aprimoramentos na funcionalidade muscular de idosos do sexo masculino
ITUA20161822A1 (it) Composizioni utili nella prevenzione e/o nel trattamento di patologie del cavo orale, delle prime vie aeree e dell’esofago
BR102019017062A8 (pt) Composições tópicas compreendendo pichia anomala e retinol
MX2021006977A (es) Anellosomas y metodos de uso.
FR3039749B1 (fr) Composition nutritionnelle hyperenergetique et enrichie en proteines
MA37532A1 (fr) Composition pharmacologique de palmarosa (huile essentielle) à effet antibactérien sur d’aaggregatibacter actinomycetemcomitans
MA37534A1 (fr) Composition pharmacologique du thym (huile essentielle) à effet antibactérien sur d’aaggregatibacter actinomycetemcomitans
MA37530A1 (fr) Composition pharmacologique de la citronnelle (huile essentielle) à effet antibactérien sur d’aggregatibacter actinomycetemcomitans
MA37533A1 (fr) Composition pharmacologique de l’origan (huile essentielle) à effet antibactérien sur d’aaggregatibacter actinomycetemcomitans
BR102019017344A8 (pt) Composições tópicas compreendendo pichia anomala e n-acetil glicosamina
MA37531A1 (fr) Composition pharmacologique du bigaradier (huile essentielle) à effet antibactérien sur d’aaggregatibacter actinomycetemcomitans
MA37529B1 (fr) Composition pharmacologique de la menthe pouliot (huile essentielle) a effet antibacterien sur l’aggregatibacter actinomycetemcomitans.
CL2018002949A1 (es) Composiciones para el cuidado bucal.
AU2015205151A1 (en) 5-hydroxy-1H-imidazole-4-carboxamide effective-dose/sensitivity prediction method and prediction device, xanthosine-monophosphate-amount measurement method, and myelodysplastic-syndrome treatment agent and treatment method
MA49960A (fr) Formulations d'anticorps inhibiteurs de masp-2 hautement concentrées à faible viscosité, kits et méthodes de traitement de sujets souffrant d'un syndrome hémolytique atypique
CL2017002192A1 (es) Método de estimación de aceite de olivas individuales en base a tecnologías no destructivas.
FR3053891B1 (fr) Diffuseur de vapeurs, notamment d'huiles essentielles